Cancer Gene Therapy Market Size, Share and Forecast Report 2024 Cancer Gene Therapy Market Size 2024 | Page 3

in the cancer gene therapy market. For instance, in August 2017, the United
States Food and Drug Administration (USFDA) approved a breakthrough
treatment for children suffering with acute lymphoblastic leukemia (ALL)
using CAR T therapy, also known as Kymriah, developed at the University of
Pennsylvania’s Abramson Cancer Center.
Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-
enquiry?enquiry-url=cancer-gene-therapy-market
North America is expected to lead the global cancer gene therapy market
throughout the forecast period (2018–2023) followed by the Europe. This is
mainly due to strong healthcare infrastructure and high expenditure in R&D
in North America. The healthcare industry in the region is undergoing major
transformation following the implementation of various healthcare reforms.
The players in the global market have been receiving approvals for the cancer
gene therapy treatments to provide better treatment to cancer patients, thus
increasing their market share. For instance, in December 2017, Celgene
Corporation and bluebird bio, Inc. announced the updated results from the
ongoing CRB-401 Phase 1 clinical study of bb2121, an investigational anti-B-
cell maturation antigen (BCMA) CAR T cell therapy, in 21 patients suffering
with late-stage relapsed/refractory multiple myeloma.
In June 2017, Cell Medica acquired the Catapult Therapy TCR Limited, a
subsidiary of Cell and Gene Therapy Catapult (CGT Catapult), and initiated a
collaboration to establish cell therapy manufacturing for Cell Medica at CGT
Catapult’s GMP manufacturing facility in Stevenage, the U.K. Some of the
other key players operating in the cancer gene therapy industry include
Genelux Corporation, Cell Genesys, Advantagene Inc., GenVec, Inc.,
BioCanCell Ltd., Adaptimmune Therapeutics plc, Bluebird bio, Inc., and
Achieve Life Sciences, Inc.
Cancer Gene Therapy Market Segmentation
By Therapy
 Gene induced immunotherapy
o Delivery of cytokines gene
o Delivery of tumor antigen gene
© P&S Intelligence. All rights reserved
3